---
title: "LabTech: The preliminary inquiry transfer price is set at 29.19 yuan/share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243837752.md"
description: "According to the Zhitong Finance APP, LabTech disclosed the pricing situation for the shareholder inquiry transfer. Based on the inquiry subscription situation on June 10, 2025, the preliminary transfer price determined for this inquiry transfer is RMB 29.19 per share. The shares intended for transfer in this inquiry have been fully subscribed, with the preliminary determination of the transferees being 5 institutional investors, and the total number of shares intended for transfer is 2,023,573 shares"
datetime: "2025-06-10T07:58:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243837752.md)
  - [en](https://longbridge.com/en/news/243837752.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243837752.md)
generator: "portal-rs"
---

# LabTech: The preliminary inquiry transfer price is set at 29.19 yuan/share

According to the Zhitong Finance APP, LabTech (688056.SH) disclosed the pricing situation for the shareholder inquiry transfer. Based on the inquiry subscription situation on June 10, 2025, the preliminary transfer price for this inquiry transfer is set at 29.19 yuan per share. The shares intended for transfer in this inquiry have been fully subscribed, with the preliminary determined transferees being five institutional investors, and the total number of shares to be transferred is 2,023,573 shares

### Related Stocks

- [688056.CN](https://longbridge.com/en/quote/688056.CN.md)

## Related News & Research

- [Alphabet (GOOGL) Stock May Be 23% Undervalued Following $25b AI Bond Raise](https://longbridge.com/en/news/296376812.md)
- [REG - Polar Cap Tech Tst - Factsheet](https://longbridge.com/en/news/296381892.md)
- [Planned Arctic Economic and Security Corridor All-Weather Road Positively Affects Sixty North Gold's Mon Gold Mine, NWT | SXNTF Stock News](https://longbridge.com/en/news/296360681.md)
- [Stocks in Play: Metro Inc.](https://longbridge.com/en/news/296508762.md)
- [APT Medical: H1 2026 revenue and profit rose over 25% year-over-year, with strong growth in core segments](https://longbridge.com/en/news/296363764.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**